Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pine tar is a natural substance obtained through the destructive distillation of pine wood, primarily from *Pinus palustris* and other species of the Pinaceae family. It has been utilized in dermatology for over a century due to its potent antipruritic, anti-inflammatory, antibacterial, and antifungal properties. The therapeutic efficacy of pine tar in treating inflammatory skin conditions such as atopic dermatitis (eczema), psoriasis, and seborrheic dermatitis is attributed to its ability to reduce DNA synthesis and mitotic activity in the epidermis, which helps normalize keratinization and reduce scaling. It is commonly formulated in therapeutic bath oils, cleansers, and ointments to provide symptomatic relief from itching and inflammation without the side effects typically associated with topical corticosteroids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pine tar.